MMR vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
- Category
- Vaccine
- Molecular Formula
- Not applicable
- Mechanism of Action
- The MMR vaccine works by stimulating the immune system to produce antibodies against measles, mumps, and rubella, without causing the diseases. This prepares the body to fight the viruses if they are encountered again, preventing or significantly reducing the severity of the diseases.
- Evidence Grade
- A (Strong scientific evidence for use and effectiveness)
Other Names
- Measles, Mumps, and Rubella Vaccine
- MMR-II
- Priorix
Primary Benefits
- Prevents measles
- Prevents mumps
- Prevents rubella
Recommended Dosage
| Children |
2 doses |
| Adults |
1 or 2 doses depending on indication |
Side Effects
- Fever
- Mild rash
- Swelling of glands in the cheeks or neck
Precautions
- Pregnancy
- Severe immunodeficiency
- Severe allergic reactions to previous dose or vaccine component
Interactions
- Immunosuppressive therapy
- Certain antiviral drugs
Key References
- CDC guidelines for MMR vaccination
- WHO position paper on Measles vaccines
No comments yet.